RT Journal Article
SR Electronic
T1 Outcomes of COVID-19: disparities by ethnicity
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.11.20210740
DO 10.1101/2020.10.11.20210740
A1 Ali, Hamad
A1 Alshukry, Abdullah
A1 Marafie, Sulaiman K
A1 AlRukhayes, Monera
A1 Ali, Yaseen
A1 Abbas, Mohammad Bu
A1 Al-Taweel, Abdullah
A1 Bukhamseen, Yousef
A1 Dashti, Mohammad H
A1 Al-Shammari, Abdullah
A1 Abu-Farha, Mohammad
A1 AbuBaker, Jehad
A1 Al-Mulla, Fahd
YR 2020
UL http://medrxiv.org/content/early/2020/10/13/2020.10.11.20210740.abstract
AB Objectives To investigate the role of ethnicity in COVID-19 outcome disparities in a cohort in Kuwait.Methods This is a retrospective analysis of 405 individuals infected with SARS-CoV-2 in Kuwait. Outcomes such as symptoms severity and mortality were considered. Multivariate logistic regression models were used to report the odds ratios (OR) for ICU admission and dying from COVID-19.Results The cohort included 290 Arabs and 115 South Asians. South Asians recorded significantly higher COVID-19 death rates compared to Arabs (33% vs. 7.6%, P value<0.001). When compared to Arabs, South Asians also had higher odds of being admitted to the ICU (OR = 6.28, 95% CI: 3.34 – 11.80, p < 0.001). South Asian patients showed 7.62 (95% CI: 3.62 – 16.02, p < 0.001) times the odds of dying from COVID-19.Conclusion COVID-19 patients with South Asians ethnicity are more likely to have worse prognosis and outcome when compared to patients with Arab ethnicity. This suggest a possible role for ethnicity in COVID-19 outcome disparities and this role is likely to be multifactorial.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://doi.org/10.6084/m9.figshare.12567881.v1 Funding Statementno funding was obtained for this studyAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was reviewed and granted an approval by the standing committee for coordination of health and medical research in the Ministry of Health in Kuwait (IRB 2020/1404).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe dataset generated during and/or analyzed during the current study is available in the Figshare repository. https://doi.org/10.6084/m9.figshare.12567881.v1